PROQR THERAPEUTICS NV (PRQR) Live Share Price, Invest From India

PROQR THERAPEUTICS NV Stock Performance

as on December 4, 2025 at 2:29 am IST

Day's Low
Day's High
$1.91
Day's Price Range
$2.02
$2
4.50%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
$1.07
52-Week Price Range
$3.71
$2
46.50%
Downside
85.33%
Upside

PROQR THERAPEUTICS NV share price movements today

Previous Close: $1.95
Open: $1.95
Volume: 1.5M
Day's Low - High: $1.91 - $2.02
52 Week Low - High: $1.07 - $3.71

PROQR THERAPEUTICS NV Historical Returns

1 Month Return: -15.55 %
3 Month Return: -15.9 %
1 Year Return: -42.07 %
3 Year Return: + 48.89 %
5 Year Return: -49.37 %

PROQR THERAPEUTICS NV Stock Fundamentals & Key Indicators

Check PROQR THERAPEUTICS NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$205.4M

EPS (TTM)

-0.484

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-43.6M

Revenue (TTM)

16.1M

Profit Margin

-264.83%

Return On Equity TTM

-103.76%

PROQR THERAPEUTICS NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PROQR THERAPEUTICS NV with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
PROQR THERAPEUTICS NV	BUY	$205.4M	-49.37%	NA	-264.83%
Insmed Incorporated	BUY	$44.1B	415.15%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$61.4B	265.31%	1408.88	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$111.1B	102.84%	29.93	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$78.6B	46.95%	17.98	32.13%

Stock Returns calculator for PROQR THERAPEUTICS NV Stock including INR - Dollar returns

The PROQR THERAPEUTICS NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

PROQR THERAPEUTICS NV investment value today

Current value as on today

₹64,142

Returns

₹35,858

(-35.86%)

Returns from PROQR THERAPEUTICS NV Stock

₹42,363 (-42.36%)

Dollar Returns*

₹6,506 (+6.51%)

Analyst Recommendation on PROQR THERAPEUTICS NV Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for PROQR THERAPEUTICS NV. Average target price of $8.88

PROQR THERAPEUTICS NV Share Price Target

Get share price movements and forecasts by analysts on PROQR THERAPEUTICS NV.

What analysts predicted

77.48%UPSIDE

Target Price

$8.88

Current Price

Analyzed by

13 Analysts

Target

$8.88

PROQR THERAPEUTICS NV target price $8.88, a slight upside of 77.48% compared to current price of $2. According to 13 analysts rating.

PROQR THERAPEUTICS NV Stock’s Investor Sentiment and Interest

Search interest for PROQR THERAPEUTICS NV Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 4, 2025 to December 4, 2025

Change:-51% versus previous 30 day period

PROQR THERAPEUTICS NV Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	1	1	3	4	6	4	4	4	3	2
Gross Profit	1	1	3	4	6	4	4	4	3	2
Operating Income	-8	-7	-6	-8	-3	-8	-10	-10	-12	-11
EBITDA	-8	-6	0	-7	-2	-8	-5	-10	-11	-10
Interest Expense	0	0	0	0	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-5	-5	-7	-2	-8	-9	-10	-12	-11
Income Tax Expense	0	0	0	0	0	-	-	-	0	-
Net Income	-8	-6	-5	-8	-2	-9	-9	-10	-12	-11
Net Profit Margin	-643.04%	-416.79%	-166.96%	-172.09%	-42.70%	-210.98%	-216.04%	-223.04%	-319.07%	-377.56%

PROQR THERAPEUTICS NV Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	10	2	-1	5	2	1	1	3	7	19
Gross Profit	9	1	-2	4	-127	1	1	3	7	19
Operating Income	-27	-39	-40	-36	-57	-42	-57	-65	-31	-30
EBITDA	-84	-120	-40	-35	-174	-48	-54	-56	-24	-24
Interest Expense	0	0	0	0	1	2	3	5	1	1
Depreciation	-	-	1	0	2	2	2	2	2	2
Income Before Tax	-20	-39	-43	-37	-56	-46	-60	-64	-27	-27
Income Tax Expense	-6	0	0	0	0	0	0	0	0	0
Net Income	-22	-41	-51	-41	-63	-56	-68	-68	-30	-29
Net Profit Margin	-221.45%	-1713.54%	2853.96%	-746.69%	-2935.64%	-4525.27%	-4549.81%	-1792.54%	-431.67%	-146.86%

PROQR THERAPEUTICS NV Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-5	-5	-7	-2	-8	-9	-10	-12	-11
Operating Cash Flow	-7	-5	-15	-6	-5	-9	-15	-11	-12
Investing Cash Flow	0	5	-17	0	16	-2	0	0	0
Financing Cash Flow	0	-1	0	0	0	71	0	0	0
Change in Cash	-8	-1	-33	-6	10	60	-16	-12	-12

PROQR THERAPEUTICS NV Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-39	-43	-37	-56	-46	-60	-64	-27	-27
Operating Cash Flow	-34	-34	-30	-43	-47	-26	-68	21	-36
Investing Cash Flow	-2	0	0	0	0	0	0	4	-4
Financing Cash Flow	0	26	88	50	14	136	-30	-2	70
Change in Cash	-35	-11	57	6	-36	111	-92	24	30

Global Institutional Holdings in PROQR THERAPEUTICS NV

Funds	Holdings
Adage Capital Partners Gp LLC	6.27%
Privium Fund Management B.V.	4.74%
Affinity Asset Advisors, LLC	3.32%
Morgan Stanley - Brokerage Accounts	2.93%
Sio Capital Management, LLC	1.97%

See all

Insights on PROQR THERAPEUTICS NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -12.17M → -11.00M (in $), with an average increase of 10.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 915.1% return, outperforming this stock by 866.2%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 174.4% return, outperforming this stock by 216.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 4.51M → 2.91M (in $), with an average decrease of 19.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, PRQR stock has moved down by -14.8%

About PROQR THERAPEUTICS NV

proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com

Organisation	PROQR THERAPEUTICS NV
Headquarters	Zernikedreef 9, Leiden, Netherlands, 2333 CK
Industry	Health Technology
CEO	Mr. Daniel Anton de Boer
E-voting on shares	Click here to vote

Key Management of PROQR THERAPEUTICS NV

Name	Title
Ms. Sandra van der Kolk	Junior Financial Controller
Mr. Daniel Anton de Boer	Founder, CEO & Member of Management Board
Dr. Gerard Platenburg Ph.D.	Co-Founder, Chief Scientific Officer & Member of Management Board
Dr. Domenico Valerio Ph.D.	Founder & Independent Member of Supervisory Board
Mr. Dennis Hom	Chief Financial Officer
Ms. Sheila Sponselee	Chief People & Operations Officer
Ms. Sarah Cue Kiely	Vice President of Investor Relations & Corporate Communications
Dr. Cristina Lopez Lopez M.D., Ph.D.	Chief Medical Officer

FAQs

What is PROQR THERAPEUTICS NV share price today?

PROQR THERAPEUTICS NV share price today is $2 as on December 4, 2025 at 2:29 am IST at the close of the market. PROQR THERAPEUTICS NV share today touched a day high of $2.02 and a low of $1.91.

What is the 52 week high and 52 week low for PROQR THERAPEUTICS NV share?

PROQR THERAPEUTICS NV share touched a 52 week high of $3.71 on December 9, 2024 and a 52 week low of $1.07 on April 9, 2025. PROQR THERAPEUTICS NV stock price today i.e. December 4, 2025 at 2:29 am IST is closed at $2,which is 46.04% down from its 52 week high and 86.92% up from its 52 week low.

What is PROQR THERAPEUTICS NV's market capitalisation today?

PROQR THERAPEUTICS NV market capitalisation is $0.00T as on December 4, 2025 at 2:29 am IST.

How to invest in PROQR THERAPEUTICS NV Stock (PRQR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for PROQR THERAPEUTICS NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PROQR THERAPEUTICS NV Shares that will get you 0.7500 shares as per PROQR THERAPEUTICS NV share price of $2 per share as on December 4, 2025 at 2:29 am IST.

What is the minimum amount required to buy PROQR THERAPEUTICS NV Stock (PRQR) from India?

Indian investors can start investing in PROQR THERAPEUTICS NV (PRQR) shares with as little as ₹90.19 or $1 (as of December 4, 2025 at 2:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹901.90 in PROQR THERAPEUTICS NV stock (as per the Rupee-Dollar exchange rate as on December 4, 2025 at 2:41 pm IST). Based on PROQR THERAPEUTICS NV share’s latest price of $2 as on December 4, 2025 at 2:29 am IST, you will get 5.0000 shares of PROQR THERAPEUTICS NV. Learn more about fractional shares .

What are the returns that PROQR THERAPEUTICS NV has given to Indian investors in the last 5 years?

PROQR THERAPEUTICS NV stock has given -49.37% share price returns and 21.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?